Post Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ
|
|
- Hugo McCarthy
- 6 years ago
- Views:
Transcription
1 Post Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ
2
3 Art of Good Cooking Good Ingredient Good donor + OK recipient Good technique Good team Good timing Good organization Well practice
4 Heart Transplant: Peri-op Issues Donor Surgical techniques Peri operative graft Failure Imm-suppressive and rejection management Renal function management
5 Issues: medium long term Renal function management Transplant Allograft Vasculopathy Malignancy CMV infection
6 Donor Management Matching Donor cardiovascular care Donor procurement and preservation
7 Donor Cardiovascular Care Minimize effects of brain dead physiology DI Hormone Vascular tone Fluid+ Electrolyte deranged Over Innotropic drug Low Hct Low plasma osmolarity
8 Donor-recipient Matching Size: Greater than 80% of recipient body weight Blood type: Identical or compatible HLA-matching: Generally not done Direct X match only in preformed antibody found in recipient
9 Donor Procurement and Preservation Preservative agent St Thomas Cardioplegia Blood Cardioplegia Celsior HTK solution Custodiol
10
11
12
13 Donor Procurement and Preservation Ischemic Time Optimum time : less than 4 hours Acceptable to 6 hours On arrival blood cardioplegia technique in long ischemic time case
14 Surgical Techniques
15
16
17
18
19
20
21
22
23 Surgical Complications Bleeding Mal alignment Flow obstruction Tricuspid regurgitation
24 Immediate Post Op Complications Pumping failure Renal failure Rejection Bleeding
25 Pumping Failure Graft preservation and Ischemic time Hyper acute rejection Acute rejection Right heart failure Pulmonary hypertension?
26 Right Side Heart Failure Most common cause of death in peri operative Right ventricle is more prone to ischemic injury Thin wall - less reserve muscle contraction Room temperature exposed
27 Right Heart Failure High CVP Distended Rt ventricle Tricuspid regurgitation High Pulmonary artery pressure(pap) +/- Low PAP but distended RV very bad sign
28 Treatments of RV Failure Decompress right side Optimal preload volume Over fill increases Tricuspid regurgitation Lower Pulmonary vascular resistance Maximum ventilation support Drugs : NTG, Isuprel, Primacor, Viagra Nitric Oxide, Illoprost Increase RV contraction Mechanical support : IABP Ventricular assist device
29
30 Left Side Failure Mostly from donor heart issues Donor pre transplant condition Ischemic time Myocardium Preservation Acute rejection is rare Mostly result of reperfusion injury
31 Treatments of LV Failure Rest myocardium : Empty beating heart Optimal innothropic drugs Optimal environment for myocardium recovery Preload / Afterload Blood gas, Electrolyte, acid base,calcium etc Mechanical Support IABP VAD
32 Ventricular Assist Device
33 Bi Ventricular (a) Cannulation for CentriMag Assist BiVAD Device Takayama H. et al.; Interact CardioVasc Thorac Surg 2011;12:
34 Rejection
35
36
37 Immunosuppressive Therapy CNI Cyclosporine A FK 506 Antimetabolite Azathioprine Mycophenolate Steroid Adrenocortical steroids Lymphocytolytic Therapy Anti-thymocyte globulin (ATG)
38 Induction Therapy RATG: Reduce Acute rejection Periop acute renal failure Long term rejection Increase Infection
39 Standard Triple therapy Preoperative Azathioprine: 4 mg/kg IV Intraoperative Methylprednisolone: 500 mg Postoperative Cyclosporine: 2-6 mg/kg po bid based on trough levels and renal function Azathioprine: 2 mg/kg/day Methylprednisolone: 125 mg IV every 8 hours for 3-4 doses, followed by prednisone Prednisone: (beginning after Methylprednisolone)1 mg/kg/day tapering over 1 week to 0.5 mg/kg/day,
40 Maintenance Immunosuppression Goal Lowest overall level of immunosuppression to prevent rejection Cyclosporine levels Low therapeutic after 1-2 years Azathioprine 1-2 mg/kg/day after 1-2 years Prednisone mg/kg/day after 1 year
41 Problem with CNI Renal toxicity esp during critical period Injured and recovering myocardium Injured renal after CPB Compromised cardiac output and renal perfusion
42 CNI free Regimens m TOR inhibitor Sirolimus (Rapamune) Everolimus (Certican) No renal toxicicty Higher rate of rejection in de novo used.
43 Strategies :Renal Shutdown Immediate Post Op Prolonged Induction Higher rate of infection CNI free regimen de novo Higher rate of rejection Lower CNI combined with mtor Forget kidneys and protect heart Renal transplant after kidney transplant?
44 Rejection Endomyocardial biopsy Acute rejeciton Hospital Out-patient
45
46 Rejection
47 Rejection
48 Rejection
49 TREATMENT OF REJECTION GRADE Mild Moderate Moderate Severe None or oral corticosteroid augmentation Oral corticosteroid augmentation or IV corticosteroids IV corticosteroids +/- ATG or OKT3
50 Infection Most of fatal infection in post op heart transplant came from Colonized pre transplant (poor condition recipient) Consequences of prolong postop heart failure; prolong intubation CMV is the most common infection problem in medium and long term
51 Infection Pre transplant prolong intubation is the most important risk factor in post transplant infection Prolong post transplant intubation must be avoid Post op renal failure contribute to fatal infection
52 Infection Bacterial - Most Common Viral Fungal
53 Infectious Prophylaxis Pathogenic Organism Cytomegalovirus Herpes simplex Toxoplasmosis Pneumocystis Oral candidiasis Prophylactic Agent Gancyclovir, Acyclovir, IVIg Acyclovir Pyrimethamine and Leucovorin TMP/SMX, Dapsone, Pentamidine Nystatin, Mycelex troches
54 Peri operative Renal Failure Poor renal perfusion Poor cardiac function Post cardio pul bypass injury CNI toxicity in not fully recovered renal Induction Therapy : give renal toxic free window period
55 Renal Failure Most important side effect of cyclosporin from afferent arteriolar vasoconstriction and direct tubular cell injury; Dose related to some extent and will improve with reduction in the Cyclosporin dose
56 Peri operative renal failure Extended induction technique Intermittent RATG after complted normal induction duration Follow CD 3 CNI free until renal recover Significantly increase infection
57 Common Dilemmas Poor cardiac function Cannot extubate Cannot start oral CNI Prolong use of RATG : over suppress Infection flare up
58 Common Dilemmas Poor cardiac function Poor urine flow Cannot start oral CNI Higher risk of rejection
59 Conclusions Donor recipient condition Most important Right side heart failure is the most common cause of operative dead Prolong poor cardiac function leaded to prolong intubation and fatal infection Post operative care is the most difficult aspect in heart transplant
60 Thank you
61
Symposium. Post-operative Management Of Pediatric Heart Transplantation : A Brief Review
DOI-10.21304/2018.0503.00394 Symposium Post-operative Management Of Pediatric Heart Transplantation : A Brief Review Balakrishnan KR*, Suresh KG**, Muralikrishna T***, Suresh Kumar R **** *Director, Cardiac
More information9/30/ DISCLOSURES. + First: Why immunosuppress? Transplant Immunosuppression and Prophylaxis
Transplant Immunosuppression and Prophylaxis Sarah Fitz, APN, MSN, ACNP-BC Loyola University Medical Center DISCLOSURES I am not being paid by any entity to endorse a specific product. Any mention of brand
More informationEmerging Drug List EVEROLIMUS
Generic (Trade Name): Manufacturer: Everolimus (Certican ) Novartis Pharmaceuticals NO. 57 MAY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence: For use with cyclosporine
More informationOBJECTIVES. Phases of Transplantation and Immunosuppression
Transplant and Immunosuppression: Texas Transplant Center April 29, 2017 Regina L. Ramirez, Pharm.D., BCPS PGY1 Pharmacy Residency Program Director Clinical Practice Specialist Solid Organ Transplant and
More informationComplications of VAD therapy - RV failure
Complications of VAD therapy - RV failure Nana Afari-Armah, MD Advanced heart failure and transplant cardiology Temple University Hospital 3/24/18 Goals Understand the role of the right ventricle in LVAD
More informationSerum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant
SDC, Patients and Methods Complement-dependent lymphocytotoxic crossmatch test () Serum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant donor-specific CXM was
More informationHeart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017
Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department of Cardiovascular
More informationMedications in the Solid Organ Transplant Recipient
Medications in the Solid Organ Transplant Recipient Monica Morgan, PharmD Transplant Pharmacist UT Southwestern Medical Center Solid Organ Transplant Program Objectives To describe the typical medications
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationOverview of New Approaches to Immunosuppression in Renal Transplantation
Overview of New Approaches to Immunosuppression in Renal Transplantation Ron Shapiro, M.D. Professor of Surgery Surgical Director, Kidney/Pancreas Transplant Program Recanati/Miller Transplantation Institute
More informationCertified Clinical Transplant Nurse (CCTN) * Detailed Content Outline
I. PRETRANSPLANTATION CARE 9 11 3 23 A. Evaluate End-Stage Organ Failure 1 1 1 3 1. History and physical assessment 2. Vital signs and / or hemodynamic parameters 3. Lab values 4. Diagnostic tests B. Monitor
More informationINTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION a Society that includes Basic Science, the Failing Heart, and Advanced Lung Disease
International Society of Heart and Lung Transplantation Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation This advisory statement has been produced by the
More informationDEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University
DEMYSTIFYING VADs Nicolle Choquette RN MN Athabasca University Objectives odefine o Heart Failure o VAD o o o o Post Operative Complications Acute Long Term Nursing Interventions What is Heart Failure?
More informationConsidering the early proactive switch from a CNI to an mtor-inhibitor (Case: Male, age 34) Josep M. Campistol
Considering the early proactive switch from a CNI to an mtor-inhibitor (Case: Male, age 34) Josep M. Campistol Patient details Name DOB ESRD Other history Mr. B.I.B. 12 January 1975 (34yo) Membranous GN
More information2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474)
1 46% 2% 3% 4% 0% 2% 2% CHD HCM ICM NICM RCM 49% 3% 3% 3% 1% 3% 3% Retransplant VCM 42% Other 35% 1/1982 6/2015 1/2009 6/2015 2016 JHLT. 2016 Oct; 35(10): 1149-1205 UNOS, 2017 Adult Heart Transplants Donor
More informationEvaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients
Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients Catherine A. Pennington, 1 Sarah M. Tischer, 1 Eliza Lee, 2 Sun Lee, 2 James Sindelar,
More informationEfficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function
ArtIcle Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function Guodong Chen, 1 Jingli Gu, 2 Jiang Qiu, 1 Changxi
More informationEuropean Risk Management Plan. Measures impairment. Retreatment after Discontinuation
European Risk Management Plan Table 6.1.4-1: Safety Concern 55024.1 Summary of Risk Minimization Measures Routine Risk Minimization Measures Additional Risk Minimization Measures impairment. Retreatment
More informationSteroid-Free Maintenance Immunosuppression After Heart Transplantation
Steroid-Free Maintenance Immunosuppression After Heart Transplantation Timothy E. Oaks, MD, Thomas Wannenberg, MD, Sherry A. Close, BSN, Laura E. Tuttle, BSN, and Neal D. Kon, MD Departments of Cardiothoracic
More informationManagement of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist
Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1999) 14: 394 399 Original Article Nephrology Dialysis Transplantation Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil Rudolf P.
More informationInduction Immunosuppression With Rabbit Antithymocyte Globulin in Pediatric Liver Transplantation
LIVER TRANSPLANTATION 12:1210-1214, 2006 ORIGINAL ARTICLE Induction Immunosuppression With Rabbit Antithymocyte Globulin in Pediatric Liver Transplantation Ashesh Shah, 1 Avinash Agarwal, 1 Richard Mangus,
More informationUNIVERSITY OF NORTH CAROLINA HOSPITAL SCUT MONKEY PROTOCOL FOR ABDOMINAL TRANAPLANT SERVICE Revised June 2013
UNIVERSITY OF NORTH CAROLINA HOSPITAL SCUT MONKEY PROTOCOL FOR ABDOMINAL TRANAPLANT SERVICE Revised June 2013 IMMUNOSUPPRESSION PROTOCOLS Adult Kidney Transplant Induction and Maintenance Algorithm Adult
More informationHeart Transplantation
Heart Transplantation Abbas Ardehali, M.D., F.A.C.S. Professor of Surgery and Medicine, Division of Cardiac Surgery William E. Connor Chair in Cardiothoracic Transplantation Director, UCLA Heart, Lung,
More informationImmunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Immunosuppressants Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Immunosuppressive Agents Very useful in minimizing the occurrence of exaggerated or inappropriate
More informationMarta Farrero Torres₁, Marcelo Pando₂, Dolly Tyan₂, Hannah Valantine₃, Spenser Smith₃, Kiran Khush₃
Development of HLA donor specific antibodies after heart transplantation: importance of a new method to detect the first component of the complement cascade Marta Farrero Torres₁, Marcelo Pando₂, Dolly
More informationHeart Transplant: State of the Art. Dr Nick Banner
Heart Transplant: State of the Art Dr Nick Banner Heart Transplantation What is achieved Current challenges Donor scarcity More complex recipients Long-term limitations Non-specific Pharmacological Immunosuppression
More informationNephrology Grand Rounds
Nephrology Grand Rounds PTLD in Kidney Transplantation Charles Le University of Colorado 6/15/12 Objectives Background Pathogenesis Epidemiology and Clinical Manifestation Incidence Risk Factors CNS Lymphoma
More informationChildhood Primary Central Nervous System Vascultis Treatment Protocols
Childhood Primary Central Nervous System Vascultis Treatment Protocols Last updated December 2014 Non-progressive large vessel primary CNS vasculitis* Adjunctive immunosuppression f 3 months IV Methylprednisolone
More informationIntruduction PSI MODE OF ACTION AND PHARMACOKINETICS
Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University
More informationResearch Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation
Transplantation Volume 2013, Article ID 236720, 6 pages http://dx.doi.org/10.1155/2013/236720 Research Article The Natural History of Biopsy-Negative Rejection after Heart Transplantation Zhaoyi Tang,
More informationPostoperative monitoring after
Postoperative monitoring after kidney transplantation Bundit sakulchairungrueng,md Vascular and Transplantation Unit Faculty of Medicine Ramathibodi Hospital Mahidol University Reference Introduction A
More informationClinical decisions regarding immunosuppressive
PHARMACOLOGIC THERAPIES AND RATIONALES * Stuart D. Russell, MD ABSTRACT This article reviews evidence related to the use of induction therapy and longer-term combination immunosuppressive drug regimens
More informationTwenty-Year Survivors of Heart Transplantation at Stanford University
American Journal of Transplantation 2008; 8: 1769 1774 Wiley Periodicals Inc. Special Article C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society
More informationAlemtuzumab Induction in Non-Hepatitis C Positive Liver Transplant Recipients
LIVER TRANSPLANTATION 17:32-37, 2011 ORIGINAL ARTICLE Alemtuzumab Induction in Non-Hepatitis C Positive Liver Transplant Recipients Josh Levitsky, 1,2 Kavitha Thudi, 1 Michael G. Ison, 1,3 Edward Wang,
More information06/04/2013 ISHLT. 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013
LUNG TRANSPLANTS The Journal of Heart and Lung Transplantation, 2012 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013 LUNG TRANSPLANTATION:STATE OF THE ART L. Santambrogio
More informationRESULTS previously reported from this center
Cyclosporine-Steroid Combination Therapy in 84 Cadaveric Renal Transplants Robert D. Gordon, MD, Shunzaburo Iwatsuki, MD, Byers W. Shaw, Jr, MD, and Thomas E. Starzl, MD, PhD Sixty-three primary and 21
More informationNAPRTCS Annual Transplant Report
North American Pediatric Renal Trials and Collaborative Studies NAPRTCS 2010 Annual Transplant Report This is a privileged communication not for publication. TABLE OF CONTENTS PAGE I INTRODUCTION 1 II
More information3/6/2017. Prevention of Complement Activation and Antibody Development: Results from the Duet Trial
Prevention of Complement Activation and Antibody Development: Results from the Duet Trial Jignesh Patel MD PhD FACC FRCP Medical Director, Heart Transplant Cedars-Sinai Heart Institute Disclosures Name:
More informationMechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography
Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography David Langholz, M.D., F.A.C.C. Co-Director Cardiovascular Imaging Fredrick Meijer Heart and Vascular Institute Spectrum
More informationLong-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center
Transplant International ISSN 934-874 ORIGINAL ARTICLE Long-term outcomes after 1 heart transplantations in six different eras of innovation in a single center Sieglinde Kofler, 1,2 Amir K. Bigdeli, 1
More informationTargeted Adverse Event (ADV)
North American Pediatric Renal Trials Collaborative Studies Production Release 14.0 [$sitecode] User: Adverse Event: Adverse Event Date: Targeted Adverse Event (ADV) Web Version: 1.0; 2.0; 06-20-13 1.
More informationSolid Organ Transplantation 1. Chapter 55. Solid Organ Transplant, Self-Assessment Questions
Solid Organ Transplantation 1 Chapter 55. Solid Organ Transplant, Self-Assessment Questions Questions 1 to 9 are related to the following case: A 38-year-old white man is scheduled to receive a living-unrelated
More informationTransplantation in Australia and New Zealand
Transplantation in Australia and New Zealand Matthew D. Jose MBBS (Adel), FRACP, FASN, PhD (Monash), AFRACMA Professor of Medicine, UTAS Renal Physician, Royal Hobart Hospital Overview CKD in Australia
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationLiver Transplant Immunosuppression
Liver Transplant Immunosuppression Michael Daily, MD, MS, FACS Surgical Director, Kidney and Pancreas Transplantation University of Kentucky Medical Center Disclosures No financial disclosures I will be
More informationThis study is currently recruiting participants.
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation This study is currently recruiting
More informationControversies in Renal Transplantation. The Controversial Questions. Patrick M. Klem, PharmD, BCPS University of Colorado Hospital
Controversies in Renal Transplantation Patrick M. Klem, PharmD, BCPS University of Colorado Hospital The Controversial Questions Are newer immunosuppressants improving patient outcomes? Are corticosteroids
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationSINCE the introduction of Imuran and
Cadaveric Renal Transplantation With Cyclosporin-A and Steroids T. R. Hakala, T. E. Starzl, J. T. Rosenthal, B. Shaw, and S. watsuki SNCE the introduction of muran and prednisone in 1961, and despite the
More informationChronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.
Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationNAPRTCS Annual Transplant Report
North American Pediatric Renal Trials and Collaborative Studies NAPRTCS 2014 Annual Transplant Report This is a privileged communication not for publication. TABLE OF CONTENTS PAGE II TRANSPLANTATION Section
More informationThe 1-year survival rate approaches 80% for patients
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Frank A. Pigula, MD, Bartley P. Griffith, MD, Marco A. Zenati, MD, James H. Dauber, MD, Samuel A. Yousem, MD, and Robert J.
More informationWhat is the Best Induction Immunosuppression Regimen in Kidney Transplantation? Richard Borrows: Queen Elizabeth Hospital Birmingham
What is the Best Induction Immunosuppression Regimen in Kidney Transplantation? Richard Borrows: Queen Elizabeth Hospital Birmingham SYMPHONY Study Ekberg et al. NEJM 2008 Excluded: DCD kidneys; CIT>30hours;
More informationJennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio
Biventricular Heart Failure Advanced Treatment Options at The Cleveland Clinic Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio I have no disclosures. Examine respiratory and
More informationChildhood Primary Central Nervous System Vascultis Treatment Protocols
Childhood Primary Central Nervous System Vascultis Treatment Protocols Last updated November 2015 Non-progressive large vessel primary CNS vasculitis* Adjunctive immunosuppression f 3 months IV Methylprednisolone
More informationExtra Corporeal Life Support for Acute Heart failure
Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical
More informationBy the way, I have a transplant..
By the way, I have a transplant.. Transplant patient for non-transplant surgery David Elliott No relevant disclosures Organ donation in Australia - 2017 Survival rates following organ donation have increased
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationGlossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.
1-Glossary Glossary Acute rejection A type of rejection that occurs when immune cells from your body attack the transplanted organ(s). Acute rejection may occur at any time after a transplant. But it usually
More informationI topic liver transplantation (OLT) to avoid organ
ORIGINAL ARTICLES Long-Term Immunosuppression Without Corticosteroids After Orthotopic Liver Transplantation: A Positive Therapeutic Aim Gerald M. Fraser, * Kons tantinos Grammous tianos, Jayendravandan
More informationLONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS
LONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS Advanced age has traditionally been a contraindication to cardiac transplantation. We have, however, offered cardiac transplantation
More informationHeart Transplantation is Dead
Heart Transplantation is Dead Alternatives to Transplantation in Heart Failure Sagar Damle, MD University of Colorado Health Sciences Center Grand Rounds September 8, 2008 Outline Why is there a debate?
More informationBK Virus (BKV) Management Guideline: July 2017
BK Virus (BKV) Management Guideline: July 2017 BK virus has up to a 60-80% seroprevalence rate in adults due to a primary oral or respiratory exposure in childhood. In the immumocompromised renal transplant
More informationTransplant in Pediatric Heart Failure
Transplant in Pediatric Heart Failure Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart and Lung Transplantation
More informationSolid Organ Transplant
Solid Organ Transplant Lee R. Goldberg, MD, MPH, FACC Associate Professor of Medicine Medical Director, Heart Failure and CardiacTransplant Program University of Pennsylvania Disclosures Thoratec Consulting
More informationImmunosuppression: evolution in practice and trends,
American Journal of Transplantation 25; 5 (Part 2): 874 886 Blackwell Munksgaard Blackwell Munksgaard 25 Immunosuppression: evolution in practice and trends, 1993 23 Ron Shapiro a,, James B. Young b, Edgar
More informationMODERATOR Felix Rapaport, other members of this
The First Lung Transplant in Man (1963) and the First Heart Transplant in Man (1964) J.D. Hardy MODERATOR Felix Rapaport, other members of this distinguished panel, and members of the audience, I will
More information2017 CST-Astellas Canadian Transplant Fellows Symposium. Management of Renal Dysfunction in Extra Renal Transplants
2017 CST-Astellas Canadian Transplant Fellows Symposium Management of Renal Dysfunction in Extra Renal Transplants Jeffrey Schiff, MD Dr. Jeffrey Schiff is an Assistant Professor of Medicine at the University
More informationImmunosuppressant medicines have allowed patients
48 Clinical Pharmacist February 2010 Vol 2 Patients who tolerate a transplanted organ without the need for pharmacological intervention are few and far between. Several immunosuppressants can be used to
More informationREACH Risk Evaluation to Achieve Cardiovascular Health
Dyslipidemia and transplantation History: An 8-year-old boy presented with generalized edema and hypertension. A renal biopsy confirmed a diagnosis of focal segmental glomerulosclerosis (FSGS). After his
More informationASSESSMENT OF THE PAEDIATRIC NEEDS IMMUNOLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref.: EMEA/381922/2006 ASSESSMENT OF THE PAEDIATRIC NEEDS IMMUNOLOGY DISCLAIMER The Paediatric Working Party
More informationDisclosures. ICU Management of Advanced Lung Disease 5/9/2015. No Disclosures. All pictures from commercial sources
Disclosures ICU Management of Advanced Lung Disease No Disclosures All pictures from commercial sources Lundy J. Campbell, MD UCSF Department of Anesthesia and Perioperative Care Division of Critical Care
More informationHeart Transplantation for Patients with a Fontan Procedure
Heart Transplantation for Patients with a Fontan Procedure Kirk R. Kanter MD Professor of Surgery Pediatric Cardiac Surgery Emory University School of Medicine Children s Healthcare of Atlanta Atlanta,
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationRenal Transplant. Tony Chacon. Program Head BCIT Nephrology Nursing Program.
Renal Transplant Tony Chacon Program Head BCIT Nephrology Nursing Program Email: tony_chacon@bcit.ca Summary of CNA Renal Transplant Competencies Potential contraindications to renal transplant. Assessment/selection
More informationHuman Heart Transplantation: Current Status
Human Heart Transplantation: Current Status Randall B. Griepp, M.D., Edward B. Stinson, M.D.," Charles P. Bieber, M.D., Bruce A. Reitz, M.D., Jack G. Copeland, M.D., Philip E. Oyer, M.D., and Norman E.
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 30 November 2011 NULOJIX 250 mg, powder for concentrate for solution for infusion B/1 (CIP code: 580 415-7) B/2 (CIP
More informationBetter than Google- Click on Immunosuppression Renal Transplant. David Landsberg Oct
Better than Google- Click on Immunosuppression Renal Transplant David Landsberg Oct 3 2008 OUTLINE History of Immunosuppression Trends in Immunosupression FK vs CYA Steroid Minimization CNI Avoidance Sirolimus
More informationWound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil-Based Regimen in Cardiac Transplant Recipients
American Journal of Transplantation 2006; 6: 986 992 Blackwell Munksgaard C 2006 The Authors Journal compilation C 2006 The American Society of Transplantation and the American Society of Transplant Surgeons
More informationFUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART
FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART CINDY BITHER, MSN, ANP, ANP, AACC, CHFN CHIEF NP, ADV HF PROGRAM MEDSTAR WASHINGTON HOSPITAL CENTER CONFLICTS OF INTEREST NONE
More informationDefinitions. You & Your New Transplant ` 38
Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)
More informationAljoša Kandus Renal Transplant Center, Department of Nephrology, University Medical Center Ljubljana, Slovenia
Aljoša Kandus Renal Transplant Center, Department of Nephrology, University Medical Center Ljubljana, Slovenia Immunosuppression in kidney transplantation Aljoša Kandus Renal Transplant Center, Department
More informationTolerance Induction in Transplantation
Tolerance Induction in Transplantation Reza F. Saidi, MD, FACS, FICS Assistant Professor of Surgery Division of Organ Transplantation Department of Surgery University of Massachusetts Medical School Percent
More informationFellows Conference 01/21/2016
Fellows Conference 01/21/2016 Outline Basics of transplantation Benefits of transplantation Immunosuppressive medications Anatomy of Renal Transplantation Recipient Selection General medical condition.
More informationScottish Medicines Consortium
Scottish Medicines Consortium tacrolimus, 5mg/ml concentrate for infusion and 0.5mg, 1mg, 5mg hard capsules (Prograf ) No. (346/07) Astellas Pharma Ltd 12 January 2007 The Scottish Medicines Consortium
More informationTransplant Hepatology
Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified
More informationCyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients
Cyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients Mohsin Hakim, F.R.C.S., M.R.C.P., John Wallwork, B.Sc., F.R.C.S., and Terence English, B.Sc., F.R.C.S. ABSTRACT Between March,
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29755 holds various files of this Leiden University dissertation. Author: Moes, Dirk Jan Alie Roelof Title: Optimizing immunosuppression with mtor inhibitors
More informationThymoglobulin induction dosing strategies in a low-risk kidney transplant population: Three or four days?
Washington University School of Medicine Digital Commons@Becker Open Access Publications 1-1-21 Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: Three or four days?
More informationCardiac surgery - CAD
Cardiac surgery - CAD University of Pecs, Medical Faculty Heart Institute http://aok.pte.hu/en/egyseg/dokumentumok/290 Treatment strategies for CAD medical nitrate, anti-tct, (lysis), beta-blocker... interventional
More informationHeart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
ESC Congress 2011 Paris 27-31 August Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients M.T. La Rovere, F. Olmetti, G.D. Pinna, R. Maestri, D. Lilleri, A. D Armini, M. Viganò,
More informationRecognition and Treatment of Chronic Allograft Dysfunction
Recognition and Treatment of Chronic Allograft Dysfunction Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas Transplant Programs
More informationORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION
European Journal of Cardio-Thoracic Surgery 48 (2015) 158 162 doi:10.1093/ejcts/ezu406 Advance Access publication 29 October 2014 ORIGINAL ARTICLE Cite this article as: Bernhardt AM, De By TMMH, Reichenspurner
More informationino in neonates with cardiac disorders
ino in neonates with cardiac disorders Duncan Macrae Paediatric Critical Care Terminology PAP Pulmonary artery pressure PVR Pulmonary vascular resistance PHT Pulmonary hypertension - PAP > 25, PVR >3,
More informationLiterature Review: Transplantation July 2010-June 2011
Literature Review: Transplantation July 2010-June 2011 James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver Kidney Transplant Top 10 List: July Kidney
More informationPost Transplant Immunosuppression: Consideration for Primary Care. Sameh Abul-Ezz, M.D., Dr.P.H.
Post Transplant Immunosuppression: Consideration for Primary Care Sameh Abul-Ezz, M.D., Dr.P.H. Objectives Discuss the commonly used immunosuppressive medications and what you need to know to care for
More informationCases: CMV, HCV, BKV and Kidney Transplantation. Simin Goral, MD University of Pennsylvania Medical Center
Cases: CMV, HCV, BKV and Kidney Transplantation Simin Goral, MD University of Pennsylvania Medical Center Disclosures Grant support: Otsuka Pharmaceuticals, Astellas Pharma, Angion, AstraZeneca, and Kadmon
More informationA Tolerance Approach to the Transplantation of Vascularized Tissues
A Tolerance Approach to the Transplantation of Vascularized Tissues The 9th New Jersey Symposium on Biomaterials Science and Regenerative Medicine October 29-31, 2008 David H. Sachs, M.D. Harvard Medical
More information